Bausch + Lomb Corporation operates as an eye health company worldwide, providing a range of products and services for vision care, ophthalmic pharmaceuticals, and surgical treatments.

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

COM:BAUSCH

Bausch + Lomb Corporation

Last Close

19.81

22/11 21:00

Market Cap

6.89B

Beta: -

Volume Today

363.23K

Avg: -

Analysis Not Available